Prudential Financial
LAB icon

Prudential Financial’s Standard BioTools LAB Stock Holding History

Prudential Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.6K Buy
60,321
+12,915
+27% +$12.2K ﹤0.01% 2420
2026
Q1 		$43.6K Buy
47,406
+28,630
+152% +$34.7K ﹤0.01% 2330
2025
Q4 		$24K Sell
18,776
-20,531
-52% -$27.6K ﹤0.01% 2189
2025
Q3 		$51.1K Hold
39,307
– – ﹤0.01% 2334
2025
Q2 		$47.2K Buy
39,307
+16,541
+73% +$18.3K ﹤0.01% 2349
2025
Q1 		$24.6K Sell
22,766
-90
-0.4% -$126 ﹤0.01% 2240
2024
Q4 		$40K Hold
22,856
– – ﹤0.01% 2232
2024
Q3 		$44.1K Hold
22,856
– – ﹤0.01% 2660
2024
Q2 		$40.5K Buy
+22,856
New +$55.9K ﹤0.01% 2634
2024
Q1 		– Sell
-21,600
Closed -$47.7K – 2714
2023
Q4 		$47.7K Buy
21,600
+6,600
+44% +$14.1K ﹤0.01% 2556
2023
Q3 		$43.5K Buy
+15,000
New +$39.2K ﹤0.01% 2512
2023
Q1 		– Sell
-21,800
Closed -$25.5K – 2639
2022
Q4 		$25.5K Hold
21,800
– – ﹤0.01% 2554
2022
Q3 		$24K Hold
21,800
– – ﹤0.01% 2622
2022
Q2 		$35K Buy
+21,800
New +$53.9K ﹤0.01% 2597
2020
Q2 		– Sell
-42,624
Closed -$108K – 2437
2020
Q1 		$108K Buy
42,624
+11,485
+37% +$37.7K ﹤0.01% 2263
2019
Q4 		$108K Buy
+31,139
New +$110K ﹤0.01% 2374
2019
Q3 		– Sell
-15,950
Closed -$197K – 2447
2019
Q2 		$197K Buy
15,950
+5,700
+56% +$72.6K ﹤0.01% 2345
2019
Q1 		$136K Buy
+10,250
New +$108K ﹤0.01% 2352
2016
Q4 		– Sell
-10,740
Closed -$86K – 2365
2016
Q3 		$86K Buy
+10,740
New +$98.6K ﹤0.01% 2283

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Prudential Financial's LAB Position: Q2 2026 in Review

Prudential Financial increased its Standard BioTools (LAB) stake by 27% in Q2 2026, buying an estimated $12.2K and bringing the position to 60,321 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

Prudential Financial first reported a position in LAB in Q3 2016 and has held it in 19 quarters since. The position peaked at $197K in Q2 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Prudential Financial held 60,321 shares of Standard BioTools worth $49.6K as of Q2 2026.
  • Prudential Financial bought 12,915 Standard BioTools shares in Q2 2026, an estimated $12.2K.
  • Standard BioTools made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2420 holding.
  • Prudential Financial first reported a position in Standard BioTools in Q3 2016 and has held it in 19 quarters since.
  • Prudential Financial's Standard BioTools position peaked at $197K in Q2 2019.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.